Want to see AU:PHX full AI Analyst Report?
Total Valuation
PharmX Technologies has a market cap or net worth of AU$62.18M. The enterprise value is AU$79.67.
Market CapAU$62.18M
Enterprise ValueAU$79.67
Share Statistics
PharmX Technologies has 668,618,650 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding668,618,650
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
PharmX Technologies’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -7.79%.
Return on Equity (ROE)-0.08
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-7.79%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee846.33K
Profits Per Employee-202.89K
Employee Count9
Asset Turnover0.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PharmX Technologies is ―. PharmX Technologies’s PEG ratio is -0.07.
PE Ratio―
PS Ratio10.58
PB Ratio3.46
Price to Fair Value3.46
Price to FCF100.11
Price to Operating Cash Flow―
PEG Ratio-0.07
Income Statement
In the last 12 months, PharmX Technologies had revenue of 7.62M and earned -1.83M in profits. Earnings per share was >-0.01.
Revenue7.62M
Gross Profit-70.00K
Operating Income-2.09M
Pretax Income-2.01M
Net Income-1.83M
EBITDA-532.00K
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was 1.30M and capital expenditures -30.00K, giving a free cash flow of 1.27M billion.
Operating Cash Flow1.30M
Free Cash Flow1.27M
Free Cash Flow per Share<0.01
Dividends & Yields
PharmX Technologies pays an annual dividend of AU$0.007, resulting in a dividend yield of 6.52%
Dividend Per ShareAU$0.007
Dividend Yield6.52%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change-28.46%
50-Day Moving Average0.10
200-Day Moving Average0.12
Relative Strength Index (RSI)46.50
Average Volume (3m)304.65K
Important Dates
PharmX Technologies upcoming earnings date is Feb 25, 2027, TBA (Confirmed).
Last Earnings DateAug 26, 2026
Next Earnings DateFeb 25, 2027
Ex-Dividend Date―
Financial Position
PharmX Technologies as a current ratio of 2.33, with Debt / Equity ratio of ―
Current Ratio2.33
Quick Ratio2.33
Debt to Market Cap<0.01
Net Debt to EBITDA3.82
Interest Coverage Ratio-47.50
Taxes
In the past 12 months, PharmX Technologies has paid -188.00K in taxes.
Income Tax-188.00K
Effective Tax Rate0.09
Enterprise Valuation
PharmX Technologies EV to EBITDA ratio is -147.67, with an EV/FCF ratio of 97.59.
EV to Sales10.31
EV to EBITDA-147.67
EV to Free Cash Flow97.59
EV to Operating Cash Flow95.22
Balance Sheet
PharmX Technologies has AU$2.57M in cash and marketable securities with AU$540.00K in debt, giving a net cash position of AU$2.03M billion.
Cash & Marketable SecuritiesAU$2.57M
Total DebtAU$540.00K
Net CashAU$2.03M
Net Cash Per Share<AU$0.01
Tangible Book Value Per ShareAU$0.02
Margins
Gross margin is ―, with operating margin of -27.44%, and net profit margin of -23.97%.
Gross Margin―
Operating Margin-27.44%
Pretax Margin-26.44%
Net Profit Margin-23.97%
EBITDA Margin-6.98%
EBIT Margin-27.44%
Analyst Forecast
The average price target for PharmX Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast4.06%
EPS Growth Forecast-625.00%